Effect of Nanomicelle Curcumin in Ulcerative Colitis
Phase 2
Recruiting
- Conditions
- Children with Ulcerative Colitis (UC).Ulcerative colitis
- Registration Number
- IRCT20191221045837N2
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Children 6-18 years old who , according to the ESPHAN Guideline , have mild to moderate active Ulcerative Colitis
Obtain informed consent from the patient/ patient's parents
Exclusion Criteria
Child with a history of underlying disease including heart, kidney, liver, biliary, gastrointestinal diseases (any gastrointestinal disease other than UC) simultaneously
Taking anticoagulants such as warfarin or antiplatelet drugs by the patient
Diabetic patients
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The Pediatric Ulcerative Colitis Activity Index (PUCAI). Timepoint: Assess the severity of the disease at baseline, at the end of the first month and at the end of the second month of treatment. Method of measurement: Stool exam and PUCAI questionnaires.;The Simple Clinical Colitis Activity Index (CSCCAI). Timepoint: Assess the severity of the disease at baseline, at the end of the first month and at the end of the second month of treatment. Method of measurement: Stool exam and CSCCAI questionnaires.
- Secondary Outcome Measures
Name Time Method